Study of Treatment of Lisfranc Injuries
Foot Injury
About this trial
This is an interventional treatment trial for Foot Injury
Eligibility Criteria
Inclusion Criteria:
Stratum 1:
- Nondislocated fractures affecting tarsometatarsal (TMT) joints II and III
- Dislocation <5mm between medial cuneiforme and base of II metatarsal (MT)
- No fractures affecting TMT joints IV and V
Stratum 2:
- Affected joints TMT II- III + any other TMT
- Any dislocation >2mm (fracture or TMT joint)
- Dislocation >5mm between medial cuneiforme and base of II MT
Exclusion Criteria:
- Open fractures
- Extra-articular metatarsal (MT) fractures
- Extremely comminuted fractures with bone loss, and slight chance of gaining proper reduction with screws
- Patients with multiple fractures
- Patients with weak co-operation (dementia, alcohol use, etc.)
- Patients with significant neuropathy or some other neurological condition, diabetes and rheumatoid arthritis
- Patients with severe circulatory disorder of the lower limb
- Injuries over 14 days
- Patients with previous foot injury or surgery
- Pregnancy
- Patients who refuse to participate
Sites / Locations
- Tampere University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Open reduction and internal fixation
Primary Arthrodesis
Conservative treatment
After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.